课题基金 / 基金详情

Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization

Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization
治疗酒精使用障碍的药物开发临床试验网络 - 合同研究组织
批准号:
10506189
负责人:
JANET RANSOM
金额:
$196.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-11 至 2023-06-10

项目摘要

项目成果

JANET RANSOM的其他基金

相似基金

相关文献

中文摘要
翻译
药物开发是国家酒精滥用和酒精中毒研究所(NIAAA)的优先项目。目前,只有三种药物被食品和药物管理局(FDA)批准用于治疗酒精使用障碍(AUD)。这些药物在临床试验中显示出了小到中等的疗效,并不是对所有人都有效,这使得寻找新的分子靶点和更有效的药物疗法变得至关重要。目前合同的目的是支持一个合同研究组织(CRO)进行治疗AUD的多个、多中心、药物疗法临床试验的所有方面。
英文摘要
Medications development is a high priority program at National Institute on Alcohol Abuse and Alcoholism (NIAAA). Currently, only three medications are approved by the Food and Drug Administration (FDA) for the treatment of alcohol use disorder (AUD). These medications have demonstrated small to moderate effect sizes in clinical trials and do not work for everyone, making the search for new molecular targets and more efficacious pharmacotherapies critical. The purpose of the current contract is to support a Contract Research Organization (CRO) to conduct all aspects of multiple, multi-center, pharmacotherapy clinical trials for the treatment of AUD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALCOHOL CUE LABORATORY STUDY TESTING ANS-6637 - CONTRACT RESEARCH ORGANIZATION STUDY AND DATA MANAGEMENT
  • 批准号:
    10037755
  • 项目类别:
  • 资助金额:
    $192.16万
  • 财政年份:
    2019
  • 负责人:
    JANET RANSOM
  • 依托单位:
IGF::OT::IGF CLINICAL TRIAL
海外基金